| ADC | Antibody Drug Conjugates |
| ADCC | Antibody Dependent Cell Cytotoxicity |
| ANOVA | Analysis of Variance |
| CAR T | Chimeric Antigen Receptor T-cell therapy |
| CI | Combination Index |
| DTX | Docetaxel |
| HER2 | Human Epidermal growth factor Receptor |
| IC50 | Inhibitory Concentration |
| MBC | Metastatic Breast Cancer |
| NCI | National Cancer Institute |
| NP | Nanoparticles |
| NTB | Neratinib |
| NTB-DTX-NP | Neratinib-Docetaxel loaded Nanoparticle |
| PGLA | Polylactitide-co-glycolide |
| TRZ-NP | Trastuzumab conjugated Nanoparticle |
| TGI | Tumor Growth Inhibition |
| TKI | Tyrosine Kinase Inhibitor |
| TRZ | Trastuzumab |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.